Moreover, these findings point towards a deleterious role of PCT in the pathogenesis of DIO, suggesting PCT as a potential novel molecular target for the treatment of obesity and associated metabolic disorders. The gene discussed is CALCA; the disease is obesity due to melanocortin 4 receptor deficiency.